Global Clinical Trial Supply And Logistics Market Set To Grow To $22bn By 2022

03 August 2018
Pharma

Visiongain has launched a new pharma report Clinical Trial Supply and Logistics Market for Pharma 2018-2028: Clinical Trial Manufacturing, Clinical Trial Logistics and Distributions, Clinical Trial Supply Chain Management, Clinical Trial Packaging, Clinical Trial Cold Chain Logistics

Pharmaceutical service providers offer a wide variety of services to drug developers and other clinical trial sponsors that form a vital part of the clinical trial supply chain. For the purposes of this report, visiongain identified three main sectors of the clinical trial supply and logistics market:

• Clinical trial material manufacturing and packaging services
• Clinical trial logistics and distribution services
• Other supply chain management services

Across the pharmaceutical industry, outsourcing has become an increasingly popular way to cut costs across all aspects of the business, by reducing internal capacity - in terms of sites maintained and headcount.

The lead analyst of the report commented “Clinical trial globalisation will continue to drive growth of this market, stimulating demand for international distribution services. Globalisation will generate complex trial supply chains, requiring greater planning and logistics support.

Technological advancements will also drive the growth in clinical trial supply and logistics market, providing efficient planning and real-time data analysis to improve supply chains mid-trial. Drug pooling for multi-trial programmes will drive the demand for regional depot network with strong transport networks to trial sites.”

Leading companies featured in the report include World Courier, DHL, Marken, FedEx, Movianto, Catalent, Patheon, Almac Group, Parexel International, Fisher Clinical Services, Packaging Coordinators Inc.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Ophthalmic Drugs market set to grow to $33bn by 2024” says new Visiongain report

The market for ophthalmic drugs is a growing one.

17 June 2019

Read

“Generic Drugs market set to grow to $424bn by 2024” says new Visiongain report

Visiongain believes the market will see more traditional pharma companies beginning to embrace the generic business in order to take advantage of higher growth rates in this area.

14 June 2019

Read

“Global Precision Cancer Diagnostic Tests market set to grow to $21.3bn by 2024” says new Visiongain report

The market players are increasingly focusing on precision therapies where drug and precision tests are developed simultaneously.

06 June 2019

Read

“Global Antifungal Drugs market set to grow to $17bn by 2024” says new Visiongain report

Market penetration and adoption of new technologies entering the market for antifungal drugs will be crucial for market growth.

04 June 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever